Press "Enter" to skip to content

Posts tagged as “Results”

Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study – BioSpace

admin 0

Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study  BioSpace “lymphoma cancer” – Google News

Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study – PRNewswire

admin 0

Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study  PRNewswire “lymphoma cancer” – Google News

CytoDyn Shares Exciting Results from their Triple-Negative Breast Cancer Treatment Program with The Stock Day Podcast (CYDY) December 5, 2019. – Stock Day Media

admin 0

CytoDyn Shares Exciting Results from their Triple-Negative Breast Cancer Treatment Program with The Stock Day Podcast (CYDY) December 5, 2019.  Stock Day Media “breast cancer” – Google News

LIDDS Interview with the LPC-004 study investigator, Professor Laurence Klotz, about the LIDDS Liproca® Depot Phase IIb study results – GlobeNewswire

admin 0

LIDDS Interview with the LPC-004 study investigator, Professor Laurence Klotz, about the LIDDS Liproca® Depot Phase IIb study results  GlobeNewswire “prostate cancer” – Google News

The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial. – UroToday

admin 0

The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial.  UroToday “prostate cancer” – Google News